Risk of Refractive Prediction Error After Cataract Surgery in Patients with Thyroid Eye Disease

References

• Brent GA. Graves’ disease. N Engl J Med. 2008;358(24):2594–2605. doi:10.1056/NEJMcp0801880
   PubMed Web of Science ®Google Scholar
• Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid. 1997;7(6):885–889. doi:10.1089/thy.1997.7.885
   PubMed Web of Science ®Google Scholar
• Tanda ML, Piantanida E, Liparulo L, et al. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab. 2013;98(4):1443–1449.
   PubMed Web of Science ®Google Scholar
• Lim SL, Lim AK, Mumtaz M, Hussein E, Wan Bebakar WM, Khir AS. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves’ disease. Thyroid. 2008;18(12):1297–1301. doi:10.1089/thy.2008.0044
   PubMed Web of Science ®Google Scholar
• Bartley GB, Fatourechi V, Kadrmas EF, et al. The chronology of Graves‘ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(4):426–434. doi:10.1016/S0002-9394(14)70439-8
   PubMed Web of Science ®Google Scholar
• Douglas RS, McCoy AN, Gupta S. Thyroid Eye Disease. Springer, New York; 2014.
   Google Scholar
• Chin YH, Ng CH, Lee MH, et al. Prevalence of thyroid eye disease in Graves’ disease: a meta-analysis and systematic review. Clin Endocrinol. 2020;93(4):363–374. doi:10.1111/cen.14296
   Web of Science ®Google Scholar
• Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–738. doi:10.1056/NEJMra0905750
   PubMed Web of Science ®Google Scholar
• Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves’ disease on orbital computed tomography. J Comput Assist Tomogr. 1979;3(6):815–819. doi:10.1097/00004728-197903060-00019
   PubMed Web of Science ®Google Scholar
• Lundström M, Dickman M, Henry Y, et al. Risk factors for refractive error after cataract surgery: analysis of 282 811 cataract extractions reported to the European Registry of quality outcomes for cataract and refractive surgery. J Cataract Refract Surg. 2018;44(4):447–452. doi:10.1016/j.jcrs.2018.01.031
   Web of Science ®Google Scholar
• Kugelberg M, Lundström M. Factors related to the degree of success in achieving target refraction in cataract surgery: Swedish National Cataract Register study. J Cataract Refract Surg. 2008;34(11):1935–1939. doi:10.1016/j.jcrs.2008.06.036
   Web of Science ®Google Scholar
• Jankauskiene J, Jarusaitiene D. Assessment of visual acuity, refraction changes, and proptosis in different ages of patients with thyroid diseases. Int J Endocrinol. 2012;2012:643275. doi:10.1155/2012/643275
   PubMed Web of Science ®Google Scholar
• Miller DC, Christopher KL, Patnaik JL, et al. Posterior capsule rupture during cataract surgery in eyes receiving intravitreal anti-VEGF injections. Curr Eye Res. 2020;46(2):1–6.
   Web of Science ®Google Scholar
• Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 2014;13(4–5):398–402. doi:10.1016/j.autrev.2014.01.013
   PubMed Web of Science ®Google Scholar
• Geiger MD, Patnaik J, Miller DC, et al. Ocular comorbidities as risk factors for refractive surprise following cataract surgery. Invest Ophthalmol Vis Sci. 2019;60(9):2072.
   Web of Science ®Google Scholar
• Khong JJ, Finch S, De Silva C, et al. Risk factors for Graves’ orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study. J Clin Endocrinol Metab. 2016;101(7):2711–2720. doi:10.1210/jc.2015-4294
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM. Smoking and risk of Graves’ disease. JAMA. 1993;269(4):479–482. doi:10.1001/jama.1993.03500040045034
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Smoking and thyroid disorders–a meta-analysis. Eur J Endocrinol. 2002;146(2):153–161. doi:10.1530/eje.0.1460153
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, Petsoglou C, Billson FA, Selva D, Ghabrial R. Refractive change in thyroid eye disease (a neglected clinical sign). Br J Ophthalmol. 2006;90(3):307–309. doi:10.1136/bjo.2005.078295
   PubMed Web of Science ®Google Scholar
• Kim WS, Chun YS, Cho BY, Lee JK. Biometric and refractive changes after orbital decompression in Korean patients with thyroid-associated orbitopathy. Eye. 2016;30(3):400–405. doi:10.1038/eye.2015.242
   PubMed Web of Science ®Google Scholar
• Shadpour JM, Menghani RM, Douglas RS, Goldberg RA, Tsirbas A. Reactivation of thyroid-associated orbitopathy after cataract surgery. Jpn J Ophthalmol. 2009;53(1):44–46. doi:10.1007/s10384-008-0607-x
   PubMed Web of Science ®Google Scholar
• Wai DC, Ho SC, Seah LL, Fong KS, Khoo DH. Severe Graves’ ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease. Thyroid. 2003;13(8):823–826. doi:10.1089/105072503768499725
   Web of Science ®Google Scholar
• Yi BP, Leng SL, Kwang LB, Rootman J. Development of thyroid-related orbitopathy following cataract surgery. Orbit. 2009;28(6):383–387. doi:10.3109/01676830903071232
   PubMedGoogle Scholar
• Ismailova DS, Fedorov AA, Grusha YO. Ocular surface changes in thyroid eye disease. Orbit. 2013;32(2):87–90. doi:10.3109/01676830.2013.764440
   PubMedGoogle Scholar
• Navarro R. The optical design of the human eye: a critical review. J Optom. 2009;2(1):3–18. doi:10.3921/joptom.2009.3
   Google Scholar
• Epitropoulos AT, Matossian C, Berdy GJ, Malhotra RP, Potvin R. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672–1677. doi:10.1016/j.jcrs.2015.01.016
   PubMed Web of Science ®Google Scholar
• Kim P, Plugfelder S, Slomovic AR. Top 5 pearls to consider when implanting advanced-technology IOLs in patients with ocular surface disease. Int Ophthalmol Clin. 2012;52(2):51–58. doi:10.1097/IIO.0b013e31824b4504
   PubMedGoogle Scholar
• Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007;26(9 Suppl 1):S16–20. doi:10.1097/ICO.0b013e31812f67ca
   PubMed Web of Science ®Google Scholar
• Chuang J, Shih KC, Chan TC, Wan KH, Jhanji V, Tong L. Preoperative optimization of ocular surface disease before cataract surgery. J Cataract Refract Surg. 2017;43(12):1596–1607. doi:10.1016/j.jcrs.2017.10.033
   PubMed Web of Science ®Google Scholar
• Marta A, Coelho J, Vieira R, et al. Biometric Predictability in Combined Cataract Surgery and Ahmed Glaucoma Valve Implantation Depending on Tube Position. Clin Ophthalmol. 2021;15:2037–2045.
   Google Scholar